Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Intellipharmaceutics International Inc.

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
0.3800+0.0500+15.15%Vol 9 855 0411Y Perf -94.50%
Feb 20th, 2019 15:59
BID0.3700 ASK0.3800
Open0.4300 Previous Close0.3300
Pre-Market- After-Trading-
 - -%  - -%
Target Price
27.50 
Analyst Rating
Hold 3.00
Potencial %
7 136.84 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.61 
Earnings Date
22nd Feb 2019

Today's Price Range

0.35000.4300

 

52wk Range

0.20007.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
26.67%
3 Months
-26.21%
6 Months
-85.38%
1 Year
-94.50%
3 Years
-98.38%
5 Years
-98.97%

Quotes

Name / TickerPriceChg.Chg.%
IPCI0.38000.050015.15
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-31.30
Leverage Ratio -2.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
90.50
EBIT Margin
-503.10
EBITDA Margin
-476.60
Pre-tax Profit Margin
-199.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
62.79
PS Ratios
3.69
Price to Cash Flow
-
Price to Free Cash Flow
-0.40
Cash Flow Per Share
-2.95
Price to Tangible Book
-0.52
Book Value per Share
-
Enterprise Value (in ths.)
3 393
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
123 469.00
ROE last 12 Months
435.21
Return on Assets (5Y Avg)
-136.51
ROA last 12 Months
-205.68
Return on Capital (5Y Avg)
-293.63
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-387.94
Assets Turnover
0.20
Receivables Turnover
1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
-
Revenue per Share
0.09
Revenue Growth 3 Years
-18.14
Revenue Growth 5 Years
3.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.91-
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Earnings Per EndEstimateRevision %Trend
8/2018 QR-0.400.00-
11/2018 QR0.00--
11/2018 FY-1.950.00-
11/2019 FY-1.000.00-
Next Report Date22nd Feb 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume9 855 041
Shares Outstanding (in ths.)19 525
Trades Count5 485
Dollar Volume2 795 766
Avg. Volume1 255 419
Avg. Weekly Volume2 632 129
Avg. Monthly Volume1 652 352
Avg. Quarterly Volume1 659 264

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

39%61%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (66.67 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.33
Moderate Buy
2.33

There are no comments yet.

News